| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/19/2003 | US20030113262 Gpib-lipid bond construct and use thereof |
| 06/19/2003 | US20030111087 Process for the isolation of a major harmful oxidant from cigarette smoke |
| 06/19/2003 | CA2784260A1 Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof |
| 06/19/2003 | CA2482309A1 Methods, devices, and preparations for intervertebral disc treatment |
| 06/19/2003 | CA2470104A1 Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation |
| 06/19/2003 | CA2469889A1 Salt forms of e-2-methoxy-n-(3-(4-(3-methyl-pyridin-3-yloxy)-phenylamino)-quinazolin-6-yl)-allyl)-acetamide, its preparation and its use against cancer |
| 06/19/2003 | CA2469679A1 Heme-regulated eukaryotic initiation factor 2 alpha kinase knockout mice and methods for use |
| 06/19/2003 | CA2469620A1 Immunisation against chlamydia trachomatis |
| 06/19/2003 | CA2469615A1 Combination cancer therapy |
| 06/19/2003 | CA2469595A1 Treatment of glioblastoma with thymosin-alpha 1 |
| 06/19/2003 | CA2469494A1 Novel chimeric tnf ligands |
| 06/19/2003 | CA2469310A1 Plasmid mediated supplementation for treating chronically ill subjects |
| 06/19/2003 | CA2469306A1 Methods and compositions for control of bone formation via modulation of sympathetic tone |
| 06/19/2003 | CA2469204A1 Prospective identification and characterization of breast cancer stem cells |
| 06/19/2003 | CA2469161A1 Nucleic acid and corresponding protein entitled 193p1e1b useful in treatment and detection of cancer |
| 06/19/2003 | CA2469049A1 Endogenous retrovirus polypeptides linked to oncogenic transformation |
| 06/19/2003 | CA2469045A1 Methods of therapy for non-hodgkin's lymphoma |
| 06/19/2003 | CA2469027A1 Human genes and gene expression products isolated from human prostate |
| 06/19/2003 | CA2468994A1 Compositions comprising epothilones and their use for the treatment of carcinoid syndrome |
| 06/19/2003 | CA2467914A1 Prion inhibiting peptides and derivatives thereof |
| 06/19/2003 | CA2467736A1 Flexible method and apparatus for high throughput production and purification of multiple proteins |
| 06/19/2003 | CA2467721A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 06/19/2003 | CA2467689A1 Stabilization of hypoxia inducible factor (hif) alpha using inhibitors of hif prolyl hydroxylase |
| 06/19/2003 | CA2465120A1 Composition and method for treating chronic allograft rejection |
| 06/19/2003 | CA2464341A1 Conductance of improperly folded proteins through the secretory pathway and related methods for treating disease |
| 06/19/2003 | CA2461491A1 Methods of screening for antagonists of apm1/gzip |
| 06/18/2003 | EP1319712A2 Fusion protein having enhanced in vivo activity of erythropoietin |
| 06/18/2003 | EP1319684A1 The preparation method of a stable polymer aqueous phase-aqueous phase emulsion and its use |
| 06/18/2003 | EP1319669A2 Tissue inhibitor of metalloproteinase type three (TIMP-3) composition and methods |
| 06/18/2003 | EP1319667A2 Solid phase method for the synthesis of peptide-spacer-lipid conjugates, conjugates synthesized thereby and targeted liposomes containing the same |
| 06/18/2003 | EP1319419A1 Method of administration of a gene of interest to a vascular tissue |
| 06/18/2003 | EP1319182A2 G-csf analog compositions and methods |
| 06/18/2003 | EP1319082A2 Expression vectors containing hybrid ubiquitin promoters |
| 06/18/2003 | EP1319078A2 38692 and 21117: dual specificity phosphatase molecules and uses therefor |
| 06/18/2003 | EP1319071A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 06/18/2003 | EP1319070A2 Mammalian receptor genes and uses |
| 06/18/2003 | EP1319069A2 Compositions and methods for the therapy and diagnosis of lung cancer |
| 06/18/2003 | EP1319067A2 Human coagulation factor vii variants |
| 06/18/2003 | EP1319066A2 Isolated human kinase proteins, nucleic acid molecules and uses thereof |
| 06/18/2003 | EP1319064A2 Gsk3 polypeptides |
| 06/18/2003 | EP1319025A2 Human antibodies against pseudomonas aeruginosa lps derived from transgenic xenomouse |
| 06/18/2003 | EP1319024A2 Methods for improving the antagonistic/agonistic properties of peptidic antagonists/agonists of the corticotropin-releasing factor receptor (crfr) |
| 06/18/2003 | EP1319023A2 An hsp70 peptide stimulating natural killer (nk) cell activity and uses thereof |
| 06/18/2003 | EP1319021A2 Atp-binding cassette protein |
| 06/18/2003 | EP1319017A2 Haemophilus influenzae basb202 polypeptide, production, vaccine and diagnostic use |
| 06/18/2003 | EP1319016A1 Modified factor viii |
| 06/18/2003 | EP1319015A2 Olfactory and pheromones g-protein coupled receptors |
| 06/18/2003 | EP1319014A1 Antisense modulation of flip-c expression |
| 06/18/2003 | EP1318841A2 Control of nk cell function and survival by modulation of ship activity |
| 06/18/2003 | EP1318840A2 PHOSPHATONIN-RELATED GENE AND i METHODS OF USE THEREOF /i |
| 06/18/2003 | EP1318839A2 Methods of treating neoplasia with combinations of target cell-specific adenovirus, chemotherapy and radiation |
| 06/18/2003 | EP1318836A2 Treatment of hyperproliferative diseases |
| 06/18/2003 | EP1318834A2 Compositions comprising mixtures of human cytokines and methods of producing the same |
| 06/18/2003 | EP1318833A2 Compositions and methods for cell dedifferentiation and tissue regeneration |
| 06/18/2003 | EP1318832A2 The diagnosis, prevention, and/or treatment of atherosclerosis and underlying and/or related diseases |
| 06/18/2003 | EP1318831A2 The diagnosis, prevention, amelioration and/or treatment of disturbed immune function induced by disturbed lipid metabolism |
| 06/18/2003 | EP1318830A2 Notch receptor agonists and uses |
| 06/18/2003 | EP1318829A1 Angiogenic agents and their uses |
| 06/18/2003 | EP1318828A1 Orally administered peptides to ameliorate atherosclerosis |
| 06/18/2003 | EP1318827A1 Polymer-modified synthetic proteins |
| 06/18/2003 | EP1318721A1 Method of blocking free radical processes which result in mediated pathology without deleterious pro-oxidant side reactions |
| 06/18/2003 | EP1212095B1 Process to make a sustained release formulation |
| 06/18/2003 | EP1200317B1 A device for spray dispensing a composition for topical application comprising vitamin e and essential fatty acids |
| 06/18/2003 | EP1032428B1 Treatment of cancer using cytokine-expressing polynucleotides and compositions therefor |
| 06/18/2003 | EP1011709A4 Inhibition of apoptotis using prosaposin receptor agonists |
| 06/18/2003 | EP0891427B1 Expression of hgv antigens and their use |
| 06/18/2003 | EP0821739B1 An adenovirus helper-virus system |
| 06/18/2003 | EP0757993B1 Preventive for circulatory diseases |
| 06/18/2003 | EP0700298B1 Therapeutic use of hemoglobin in the treatment of blood vessel blockage |
| 06/18/2003 | EP0638124B1 Oral infection of insect larvae with pre-occluded baculovirus particles |
| 06/18/2003 | EP0538404B1 Fibroblast growth factor receptors |
| 06/18/2003 | CN1425073A 病毒株 Strains |
| 06/18/2003 | CN1425066A Novel stra6 polypeptides |
| 06/18/2003 | CN1425065A Method of controlling telomere length |
| 06/18/2003 | CN1425062A Dioxygenases catalyzing asymetric cleavage of beta-carotene |
| 06/18/2003 | CN1425026A Cyclic hexapeptide derivatives |
| 06/18/2003 | CN1425025A Daptomycin analogs as antibacterial agents |
| 06/18/2003 | CN1424926A Synergistic inhibition of viral replication long-chain hydrocarbons and nucleoside analogs |
| 06/18/2003 | CN1424916A Implantable substrates for healing connective tissue |
| 06/18/2003 | CN1424915A Oral, nasal and pulmonary dosage formulations of copolymer1 |
| 06/18/2003 | CN1424909A Formulations for use in inhaler devices |
| 06/18/2003 | CN1424900A Topical skin composition |
| 06/18/2003 | CN1424870A Nuclear transfer with selected donor cells |
| 06/18/2003 | CN1424324A Cell death regulating protein concerned with heart failure |
| 06/18/2003 | CN1111520C Matrix metalloprotease inhibitors |
| 06/18/2003 | CN1111429C Urease-based vaccine against HeIicobacter infection |
| 06/17/2003 | US6579975 Consensus phytases |
| 06/17/2003 | US6579973 Compositions for the treatment and diagnosis of breast cancer and methods for their use |
| 06/17/2003 | US6579972 An antibody having a specific binding affinity to a polypeptide of given amino acid sequence; can use in treating diabetes, skeletal muscle diseases, Alzheimer's disease, or peripheral neuropathies with an agonist or antagonist |
| 06/17/2003 | US6579970 Specific octapeptides, antibodies that recognize and bind to these compounds, polynucleotides that encode these compounds and immune effector cells raised in response to presentation of these epitopes. |
| 06/17/2003 | US6579969 Purified polypeptide of given amino acid sequence; serine/threonine kinase |
| 06/17/2003 | US6579968 Cyclic peptide of given amino acid sequence; stimulates male erection; less side effects; melanocortin receptor-specific pharmaceutical composition |
| 06/17/2003 | US6579899 Composition for treatment of stress |
| 06/17/2003 | US6579890 Matrix metalloprotease inhibitors |
| 06/17/2003 | US6579867 Azepin-2-one derivatives useful for treating Alzheimer's disease |
| 06/17/2003 | US6579856 Inhibition of stress activated protein kinase (SAPK) pathway and sensitization of cells to cancer therapies |
| 06/17/2003 | US6579855 Adenovirus-mediated gene therapy |
| 06/17/2003 | US6579852 OBG3 globular head and uses thereof for decreasing body mass |
| 06/17/2003 | US6579851 Effects of glucagon-like peptide-1 (7-36) on antro-pyloro-duodenal motility |
| 06/17/2003 | US6579850 Polypeptide, novel DNA and novel antibody |